MarketBeat Instant News Alerts 2 hours agoResearch Analysts Set Expectations for POET FY2029 EarningsMarketBeatPOET Technologies Inc. (NASDAQ:POET - Free Report) - Research analysts at Zacks Research issued their FY2029 earnings estimates for shares of POET Technologies in a research note issued to investors on Wednesday, August 26th. Zacks Research analyst L. Thompson expects that the company will earn $0.4NASDAQ:POETRead Research Analysts Set Expectations for POET FY2029 Earnings2 hours agoFY2028 Earnings Estimate for Intuit Issued By KeyCorpMarketBeatIntuit Inc. (NASDAQ:INTU - Free Report) - Equities researchers at KeyCorp issued their FY2028 earnings per share (EPS) estimates for Intuit in a report issued on Wednesday, August 26th. KeyCorp analyst A. Markgraff forecasts that the software maker will post earnings of $26.84 per share for the yearNASDAQ:INTURead FY2028 Earnings Estimate for Intuit Issued By KeyCorp2 hours agoSprinklr (NYSE:CXM) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPSMarketBeatSprinklr (NYSE:CXM - Get Free Report) announced its earnings results on Wednesday. The company reported $0.11 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.10 by $0.01. The business had revenue of $213.74 million for the quarter, compared to analyst estimates of $214.45 million. Sprinklr had a return on equity of 8.13% and a net margin of 3.29%.NYSE:CXMRead Sprinklr (NYSE:CXM) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS2 hours agoRoyal Bank Of Canada Upgrades 10x Genomics (NASDAQ:TXG) to "Hold"MarketBeatRoyal Bank Of Canada raised shares of 10x Genomics to a "hold" rating in a report on Tuesday.NASDAQ:TXGRead Royal Bank Of Canada Upgrades 10x Genomics (NASDAQ:TXG) to "Hold"2 hours agoBlossomHill Therapeutics (NASDAQ:BLSM) Upgraded by Leerink Partners to "Strong-Buy" RatingMarketBeatLeerink Partners raised BlossomHill Therapeutics to a "strong-buy" rating in a report on Tuesday.NASDAQ:BLSMRead BlossomHill Therapeutics (NASDAQ:BLSM) Upgraded by Leerink Partners to "Strong-Buy" Rating2 hours agoBlossomHill Therapeutics (NASDAQ:BLSM) Upgraded to Strong-Buy at HC WainwrightMarketBeatHC Wainwright upgraded shares of BlossomHill Therapeutics to a "strong-buy" rating in a research note on Tuesday.NASDAQ:BLSMRead BlossomHill Therapeutics (NASDAQ:BLSM) Upgraded to Strong-Buy at HC Wainwright Trending News1Bank of America Has Lowered Expectations for Rocket Lab (NASDAQ:RKLB) Stock Price2Headlands Technologies LLC Buys New Position in Plug Power, Inc. $PLUG3Insider Buying: AST SpaceMobile (NASDAQ:ASTS) Director Buys $619,234.84 in Stock4NIO (NYSE:NIO) Stock Price Down 2.5% - Here's What Happened5Alyeska Investment Group L.P. Has $26.44 Million Stake in Fermi Inc. $FRMI6Archer Aviation Inc. (NYSE:ACHR) Receives Consensus Recommendation of "Hold" from Analysts7Roblox (NYSE:RBLX) Stock Price Up 4.9% - Here's Why8Intuitive Machines (NASDAQ:LUNR) Stock Price Expected to Rise, Bank of America Analyst Says All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoBlossomHill Therapeutics (NASDAQ:BLSM) Stock Rating Upgraded by GuggenheimMarketBeatNASDAQ:BLSMRead BlossomHill Therapeutics (NASDAQ:BLSM) Stock Rating Upgraded by Guggenheim2 hours agoAssembly Biosciences (NASDAQ:ASMB) Upgraded by UBS Group to "Strong-Buy" RatingMarketBeatNASDAQ:ASMBRead Assembly Biosciences (NASDAQ:ASMB) Upgraded by UBS Group to "Strong-Buy" Rating2 hours agoAclaris Therapeutics (NASDAQ:ACRS) Upgraded by Canaccord Genuity Group to "Strong-Buy" RatingMarketBeatNASDAQ:ACRSRead Aclaris Therapeutics (NASDAQ:ACRS) Upgraded by Canaccord Genuity Group to "Strong-Buy" Rating2 hours agoLatigo Biotherapeutics (NASDAQ:LTGO) Upgraded at Leerink PartnersMarketBeatNASDAQ:LTGORead Latigo Biotherapeutics (NASDAQ:LTGO) Upgraded at Leerink Partners2 hours agoLatigo Biotherapeutics (NASDAQ:LTGO) Stock Rating Upgraded by Jefferies Financial GroupMarketBeatNASDAQ:LTGORead Latigo Biotherapeutics (NASDAQ:LTGO) Stock Rating Upgraded by Jefferies Financial Group2 hours agoLatigo Biotherapeutics (NASDAQ:LTGO) Stock Rating Upgraded by GuggenheimMarketBeatNASDAQ:LTGORead Latigo Biotherapeutics (NASDAQ:LTGO) Stock Rating Upgraded by Guggenheim2 hours agoLatigo Biotherapeutics (NASDAQ:LTGO) Upgraded by The Goldman Sachs Group to Strong-Buy RatingMarketBeatNASDAQ:LTGORead Latigo Biotherapeutics (NASDAQ:LTGO) Upgraded by The Goldman Sachs Group to Strong-Buy Rating2 hours agoInteractive Brokers Group (NASDAQ:IBKR) Rating Increased to Hold at UBS GroupMarketBeatNASDAQ:IBKRRead Interactive Brokers Group (NASDAQ:IBKR) Rating Increased to Hold at UBS Group2 hours agoNeedham & Company LLC Upgrades Red Violet (NASDAQ:RDVT) to Moderate BuyMarketBeatNASDAQ:RDVTRead Needham & Company LLC Upgrades Red Violet (NASDAQ:RDVT) to Moderate Buy2 hours agoPatrick Industries (NASDAQ:PATK) Rating Increased to Strong-Buy at Northcoast ResearchMarketBeatNASDAQ:PATKRead Patrick Industries (NASDAQ:PATK) Rating Increased to Strong-Buy at Northcoast Research2 hours agoZIM Integrated Shipping Services (NYSE:ZIM) Stock Rating Lowered by Zacks ResearchMarketBeatNYSE:ZIMRead ZIM Integrated Shipping Services (NYSE:ZIM) Stock Rating Lowered by Zacks Research2 hours agoVertiv (NYSE:VRT) Stock Rating Lowered by Zacks ResearchMarketBeatNYSE:VRTRead Vertiv (NYSE:VRT) Stock Rating Lowered by Zacks Research2 hours agoImpinj (NASDAQ:PI) Downgraded by Zacks Research to HoldMarketBeatNASDAQ:PIRead Impinj (NASDAQ:PI) Downgraded by Zacks Research to Hold2 hours agoOld Second Bancorp (NASDAQ:OSBC) Downgraded to Hold Rating by Zacks ResearchMarketBeatNASDAQ:OSBCRead Old Second Bancorp (NASDAQ:OSBC) Downgraded to Hold Rating by Zacks Research2 hours agoZacks Research Downgrades Newell Brands (NASDAQ:NWL) to HoldMarketBeatNASDAQ:NWLRead Zacks Research Downgrades Newell Brands (NASDAQ:NWL) to Hold2 hours agoNutanix (NASDAQ:NTNX) Lowered to "Hold" Rating by Zacks ResearchMarketBeatNASDAQ:NTNXRead Nutanix (NASDAQ:NTNX) Lowered to "Hold" Rating by Zacks Research2 hours agoLyft (NASDAQ:LYFT) Upgraded by Rosenblatt Securities to "Hold" RatingMarketBeatNASDAQ:LYFTRead Lyft (NASDAQ:LYFT) Upgraded by Rosenblatt Securities to "Hold" Rating2 hours agoInvestar (NASDAQ:ISTR) Downgraded by Zacks Research to "Hold"MarketBeatNASDAQ:ISTRRead Investar (NASDAQ:ISTR) Downgraded by Zacks Research to "Hold"2 hours agoInnoviva (NASDAQ:INVA) Rating Increased to Hold at Zacks ResearchMarketBeatNASDAQ:INVARead Innoviva (NASDAQ:INVA) Rating Increased to Hold at Zacks Research2 hours agoeToro Group (NASDAQ:ETOR) Stock Rating Upgraded by KeyCorpMarketBeatNASDAQ:ETORRead eToro Group (NASDAQ:ETOR) Stock Rating Upgraded by KeyCorp2 hours agoGilead Sciences (NASDAQ:GILD) Raised to "Strong-Buy" at Zacks ResearchMarketBeatNASDAQ:GILDRead Gilead Sciences (NASDAQ:GILD) Raised to "Strong-Buy" at Zacks Research2 hours agoFox Factory (NASDAQ:FOXF) Upgraded by Zacks Research to "Strong-Buy" RatingMarketBeatNASDAQ:FOXFRead Fox Factory (NASDAQ:FOXF) Upgraded by Zacks Research to "Strong-Buy" Rating2 hours agoExpedia Group (NASDAQ:EXPE) Stock Rating Upgraded by Rosenblatt SecuritiesMarketBeatNASDAQ:EXPERead Expedia Group (NASDAQ:EXPE) Stock Rating Upgraded by Rosenblatt Securities2 hours agoDoorDash (NASDAQ:DASH) Upgraded at Rosenblatt SecuritiesMarketBeatNASDAQ:DASHRead DoorDash (NASDAQ:DASH) Upgraded at Rosenblatt Securities Featured Articles and OffersStrike a Balance Between Growth and Stability With These 3 Names Ready to RallyBy Nathan Reiff | August 30, 2026Your $29.97 book is free todayFrom Profits Run (Ad)Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-RaiseBy Thomas Hughes | August 26, 20265 Stocks to Buy in September Before Wall Street Catches OnBy Thomas Hughes | August 26, 2026Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes ShapeBy Thomas Hughes | August 27, 2026Elon Musk’s Hushed FCC Filing. Sept 25th.From Paradigm Press (Ad)NVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout IsBy Thomas Hughes | August 27, 2026Palantir's Kool-Aid Moment: The Math Behind Karp's ForecastBy Chris Markoch | August 26, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 622 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
